In order to provide a common standard for the treatment of mycosis fungoides (MF) and
Sézary syndrome (SS), the European Organisation for Research and Treatment of Cancer …

Disease overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Cutaneous T-cell lymphomas (CTCLs) encompass a heterogeneous collection of non-
Hodgkin lymphomas that arise from skin-tropic memory T lymphocytes. Among them …

Disease overview: Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Opinion statement While most patients with early-stage mycosis fungoides (MF) follow an
indolent course, patients with advanced-stage MF/Sézary syndrome (SS) have a poor …

Purpose This phase III, placebo-controlled, randomized trial was designed to investigate
efficacy and safety of two doses of denileukin diftitox (DD; DAB389–interleukin-2 [IL-2]), a …

A complete guide to the diagnosis and management of cutaneous lymphomas and
pseudolymphomas Easily misdiagnosed as benign skin diseases, malignant cutaneous …

Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma variant
and is closely related to a rare leukemic variant, Sézary syndrome (SS). MF patients at risk of …

Sézary syndrome (SS) has a poor prognosis and few guidelines for optimizing therapy. The
US Cutaneous Lymphoma Consortium, to improve clinical care of patients with SS and …

The most common subtypes of primary cutaneous T-cell lymphomas are mycosis fungoides
(MF) and Sézary syndrome (SS). The majority of patients have indolent disease; and given …